learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
Search
forLearn
5 / 801 resultslearn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
learn sh-Polypeptide-7
learn Thymosin Beta 4
learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Research
5 / 1000+ resultsresearch Pharmaceutical evaluation of different shampoo brands in local Saudi market
All evaluated shampoos meet Saudi standards.
research Pharmaceutical Evaluation and Comparison of Popular Herbal Shampoo Brands with Synthetic Shampoo Brands of India
Both herbal and synthetic shampoos in India are generally safe and effective.
research Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
research PHARMACEUTICO- ANALYTICAL AND IN VITRO ANTI-FUNGAL EVALUATION OF POLYHERBAL SHAMPOO IN RELATION TO DANDRUFF
The polyherbal shampoo effectively treats dandruff and is a safe, natural option.
research PHARMACEUTICO- ANALYTICAL AND IN VITRO ANTI-FUNGAL EVALUATION OF POLYHERBAL SHAMPOO IN RELATION TO DANDRUFF
The polyherbal shampoo effectively treats dandruff and is a safe, natural option.
Community Join
5 / 613 resultscommunity PP405 Update and My Take on Pelage
Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.
community Scalp Massages /scalp hair oiling effective??
The conversation discusses the effectiveness of natural remedies like scalp massages and oils for hair loss, with some users advocating for proven treatments like minoxidil and finasteride. The original poster prefers natural methods, while others argue that pharmaceuticals are more effective in combating hair loss.
community Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.
community GT20029 China Phase II Trial For AGA Reached Primary Endpoint
The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.
community First patient dosed with Pyrilutamide (Kintor) Phase III
First patient dosed with Pyrilutamide (Kintor) Phase III for hair loss treatment. Pyrilutamide differs from approved treatments as it competes with DHT to bind hair follicles, potentially reducing side effects.